Moneycontrol PRO
you are here: HomeNewsTrendsHealth

Over 50% of Mumbai children have COVID-19 antibodies, says BMC after sero survey

The survey conducted by the civic-run BYL Nair Hospital and Kasturba Molecular Diagnostic Laboratory (KMDL) also revealed that the proportion of the pediatric population having antibodies has increased compared to the earlier sero-survey, the Brihanmumbai Municipal Corporation (BMC) said in a release.

June 28, 2021 / 07:40 PM IST

A paediatric sero-survey conducted before the anticipated third wave of the pandemic has revealed that 51.18 percent of children between 1 to 18 years in Mumbai have developed antibodies against coronavirus, the city civic body said on Monday.

A total of 2,176 blood samples were tested for this study conducted between April and June, it said.

The survey conducted by the civic-run BYL Nair Hospital and Kasturba Molecular Diagnostic Laboratory (KMDL) also revealed that the proportion of the pediatric population having antibodies has increased compared to the earlier sero-survey, the Brihanmumbai Municipal Corporation (BMC) said in a release.

Follow our LIVE blog for latest updates of the novel coronavirus pandemic

A sero-survey involves testing of blood serum of a group of people and the findings are used to monitor trends in prevalence.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

As a possible third wave of COVID-19 is anticipated to affect children disproportionately, the BMC had directed to conduct the sero-survey of the pediatric population during the second wave itself.

The BMC said this was the third sero -survey conducted since the beginning of the pandemic.

This survey was conducted between April 1 to June 15 in which 2,176 blood samples were collected from pathology laboratories including 1,283 samples from Aapli Chikitsa Network and the Nair Hospital of BMC, and 893 from a network of two private laboratories across 24 municipal wards.

The key findings of this study suggest that more than 50 per cent of the children have already been exposed to SARS-COV-2.

"The overall sero-positivity is 51.18 per cent including 54.36 per cent from the public sector and 47.03 per cent from the private sector," the release said, adding that sero-positivity is the highest in the age group 10-14 years at 53.43 per cent.

The sero-positivity rate in children of 1 to 4 years is 51.04 per cent, while it is 47.33 per cent in the age group of 5 to 9 years, 53.43 per cent in 10 to 14 years, and 51.39 per cent in 15 to 18 years.

The overall sero-positivity rate of 1 to 18 years is 51.18 per cent, it said.

"There is a notable increase in sero-positivity in the pediatric population to SARS-CoV-2 in this study as compared to the sero survey-3 conducted in March 2021, which showed a sero-positivity of 39.4 percent in the age group of ≤18 years, which indicates that a significant proportion of children accessing the healthcare services were exposed to the virus during the second wave of the COVID-19," the release said.

Follow our full coverage of the coronavirus pandemic here.
PTI
first published: Jun 28, 2021 07:05 pm
Sections
ISO 27001 - BSI Assurance Mark